Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Outer-Membrane-Vesicle-Associated O Antigen, a Crucial Component for Protecting Against Bordetella parapertussis Infection.

Bottero D, Zurita ME, Gaillard ME, Carriquiriborde F, Martin Aispuro P, Elizagaray M, Bartel E, Castuma C, Hozbor D.

Front Immunol. 2018 Oct 29;9:2501. doi: 10.3389/fimmu.2018.02501. eCollection 2018.

2.

Membrane Vesicles Derived from Bordetella bronchiseptica: Active Constituent of a New Vaccine against Infections Caused by This Pathogen.

Bottero D, Zurita ME, Gaillard ME, Bartel E, Vercellini C, Hozbor D.

Appl Environ Microbiol. 2018 Jan 31;84(4). pii: e01877-17. doi: 10.1128/AEM.01877-17. Print 2018 Feb 15.

3.

Pertussis Maternal Immunization: Narrowing the Knowledge Gaps on the Duration of Transferred Protective Immunity and on Vaccination Frequency.

Gaillard ME, Bottero D, Zurita ME, Carriquiriborde F, Martin Aispuro P, Bartel E, Sabater-Martínez D, Bravo MS, Castuma C, Hozbor DF.

Front Immunol. 2017 Sep 6;8:1099. doi: 10.3389/fimmu.2017.01099. eCollection 2017.

4.

Characterization of the immune response induced by pertussis OMVs-based vaccine.

Bottero D, Gaillard ME, Zurita E, Moreno G, Martinez DS, Bartel E, Bravo S, Carriquiriborde F, Errea A, Castuma C, Rumbo M, Hozbor D.

Vaccine. 2016 Jun 14;34(28):3303-9. doi: 10.1016/j.vaccine.2016.04.079. Epub 2016 May 3.

PMID:
27151884
5.

Strategies and new developments to control pertussis, an actual health problem.

Gaillard ME, Bottero D, Moreno G, Rumbo M, Hozbor D.

Pathog Dis. 2015 Nov;73(8):ftv059. doi: 10.1093/femspd/ftv059. Epub 2015 Aug 9. Review.

6.

Characterization of the key antigenic components of pertussis vaccine based on outer membrane vesicles.

Ormazábal M, Bartel E, Gaillard ME, Bottero D, Errea A, Zurita ME, Moreno G, Rumbo M, Castuma C, Flores D, Martín MJ, Hozbor D.

Vaccine. 2014 Oct 21;32(46):6084-90. doi: 10.1016/j.vaccine.2014.08.084. Epub 2014 Sep 19.

PMID:
25240753
7.

Immunization with the recombinant Cholera toxin B fused to Fimbria 2 protein protects against Bordetella pertussis infection.

Olivera N, Castuma CE, Hozbor D, Gaillard ME, Rumbo M, Gómez RM.

Biomed Res Int. 2014;2014:421486. doi: 10.1155/2014/421486. Epub 2014 May 13.

8.

Global population structure and evolution of Bordetella pertussis and their relationship with vaccination.

Bart MJ, Harris SR, Advani A, Arakawa Y, Bottero D, Bouchez V, Cassiday PK, Chiang CS, Dalby T, Fry NK, Gaillard ME, van Gent M, Guiso N, Hallander HO, Harvill ET, He Q, van der Heide HG, Heuvelman K, Hozbor DF, Kamachi K, Karataev GI, Lan R, Lutyńska A, Maharjan RP, Mertsola J, Miyamura T, Octavia S, Preston A, Quail MA, Sintchenko V, Stefanelli P, Tondella ML, Tsang RS, Xu Y, Yao SM, Zhang S, Parkhill J, Mooi FR.

MBio. 2014 Apr 22;5(2):e01074. doi: 10.1128/mBio.01074-14.

9.

Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes.

Gaillard ME, Bottero D, Errea A, Ormazábal M, Zurita ME, Moreno G, Rumbo M, Castuma C, Bartel E, Flores D, van der Ley P, van der Ark A, F Hozbor D.

Vaccine. 2014 Feb 12;32(8):931-7. doi: 10.1016/j.vaccine.2013.12.048. Epub 2014 Jan 4.

PMID:
24397896
10.

Outer membrane vesicles derived from Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection.

Bottero D, Gaillard ME, Errea A, Moreno G, Zurita E, Pianciola L, Rumbo M, Hozbor D.

Vaccine. 2013 Oct 25;31(45):5262-8. doi: 10.1016/j.vaccine.2013.08.059. Epub 2013 Sep 5.

PMID:
24012570
11.

Bordetella holmesii in children suspected of pertussis in Argentina.

Bottero D, Griffith MM, Lara C, Flores D, Pianciola L, Gaillard ME, Mazzeo M, Zamboni MI, Spoleti MJ, Anchart E, Ruggeri D, Sorhouet C, Fiori S, Galas M, Tondella ML, Hozbor DF.

Epidemiol Infect. 2013 Apr;141(4):714-7. doi: 10.1017/S095026881200132X. Epub 2012 Jul 5.

PMID:
22874073
12.

Genotypic and phenotypic characterization of Bordetella pertussis strains used in different vaccine formulations in Latin America.

Bottero D, Gaillard ME, Basile LA, Fritz M, Hozbor DF.

J Appl Microbiol. 2012 Jun;112(6):1266-76. doi: 10.1111/j.1365-2672.2012.05299.x. Epub 2012 Apr 25.

13.

Laboratory adaptation of Bordetella pertussis is associated with the loss of type three secretion system functionality.

Gaillard ME, Bottero D, Castuma CE, Basile LA, Hozbor D.

Infect Immun. 2011 Sep;79(9):3677-82. doi: 10.1128/IAI.00136-11. Epub 2011 Jul 5.

14.

Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate.

Asensio CJ, Gaillard ME, Moreno G, Bottero D, Zurita E, Rumbo M, van der Ley P, van der Ark A, Hozbor D.

Vaccine. 2011 Feb 11;29(8):1649-56. doi: 10.1016/j.vaccine.2010.12.068. Epub 2011 Jan 4.

PMID:
21211579
15.

Pertussis epidemiology in Argentina: trends over 2004-2007.

Hozbor D, Mooi F, Flores D, Weltman G, Bottero D, Fossati S, Lara C, Gaillard ME, Pianciola L, Zurita E, Fioriti A, Archuby D, Galas M, Binsztein N, Regueira M, Castuma C, Fingermann M, Graieb A.

J Infect. 2009 Oct;59(4):225-31. doi: 10.1016/j.jinf.2009.07.014. Epub 2009 Aug 3. Review.

PMID:
19651156
16.

Outer membrane vesicles as acellular vaccine against pertussis.

Roberts R, Moreno G, Bottero D, Gaillard ME, Fingermann M, Graieb A, Rumbo M, Hozbor D.

Vaccine. 2008 Aug 26;26(36):4639-46. doi: 10.1016/j.vaccine.2008.07.004. Epub 2008 Jul 18.

PMID:
18640169
17.

Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.

Bottero D, Gaillard ME, Fingermann M, Weltman G, Fernández J, Sisti F, Graieb A, Roberts R, Rico O, Ríos G, Regueira M, Binsztein N, Hozbor D.

Clin Vaccine Immunol. 2007 Nov;14(11):1490-8. Epub 2007 Aug 15.

18.

Differences of circulating Bordetella pertussis population in Argentina from the strain used in vaccine production.

Fingermann M, Fernández J, Sisti F, Rodríguez ME, Gatti B, Bottero D, Graieb A, Gaillard ME, Ayala SG, Mooi FR, Lopardo H, Hozbor D.

Vaccine. 2006 Apr 24;24(17):3513-21. Epub 2006 Feb 28.

PMID:
16545509
19.

Constitutive expression of bvgR-repressed factors is not detrimental to the Bordetella bronchiseptica-host interaction.

Fernández J, Sisti F, Bottero D, Gaillard ME, Hozbor D.

Res Microbiol. 2005 Sep;156(8):843-50.

PMID:
16002267

Supplemental Content

Loading ...
Support Center